General MedicationsORALGeneric

TOFRANIL-PM

IMIPRAMINE PAMOATE

Standard Dose

EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview TOFRANIL-PM is listed in Drugs@FDA under application 017090 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient IMIPRAMINE PAMOATE Form and strength CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SPECGX LLC Submission history Latest submission status date: 2014-07-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview TOFRANIL-PM is listed in Drugs@FDA under application 017090 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient IMIPRAMINE PAMOATE Form and strength CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SPECGX LLC Submission history Latest submission status date: 2014-07-28 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.